From Survivor to Advocate Part 2: Maimah Karmo on Her Journey and Tigerlily Foundation’s Life-Changing Programs

Delving Beyond the Infusion With Dr. Jennifer Brown and the AMPLIFY Trial’s Oral Breakthrough for CLL

In this episode, we sit down with Jennifer R. Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, to unpack the AMPLIFY trial that is reshaping chronic lymphocytic leukemia (CLL) treatment. She explains how this new oral combination isn’t just effective but patient-friendly, cutting down on complexity and paving the way for more accessible care. Tune in to hear how this breakthrough is setting the stage for the future of CLL therapy.

Advancing Treatments for Prostate and Bladder Cancers and Ensuring Equitable Access to Care: An Interview with Dr. Walter Stadler

Dr. Walter Stadler shares insights on the current treatment landscape for prostate and bladder cancers and emphasizes the importance of improving access to care for all patients.

Revolutionizing Cancer Care: Dr. Enrique Velazquez Villarreal on AI-HOPE and the Future of Oncology

Dr. Enrique Velazquez Villarreal, Assistant Professor in Department of Integrative Translational Sciences at City of Hope, discusses how his innovative AI tool, AI-HOPE, is revolutionizing cancer care by combining clinical data, genomics, and social determinants of health to enhance personalized treatments and patient outcomes.

Advancing the Fight Against Cholangiocarcinoma: Dr. Ghassan Abou-Alfa on Global Impact and Research Progress

Dr. Ghassan Abou-Alfa, a renowned medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the global impact of cholangiocarcinoma and the pivotal role of the CCA Summit in driving research, collaboration, and improved patient care.

From Survivor to Advocate Part 2: Maimah Karmo on Her Journey and Tigerlily Foundation’s Life-Changing Programs

In Part 2 of our interview with Maimah Karmo we dive deeper into her advocacy work addressing health disparities in breast cancer care. Discover how Tigerlily is driving change through initiatives that empower underrepresented communities and advance equity in cancer outcomes.